IRF81CD8+T,

Zhen Yuan1,2,3,4, Li Shu1,2,3,4, Yidan Zheng5

  • 1Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou, 310009, China.

概括

干扰素调节因子8 (IRF8) 驱动树突细胞分化,促进CD8+ T细胞的招募和腹腔大动脉动脉瘤 (AAA) 的发展. 抑制IRF8可能为AAA提供治疗策略.